Proxinium

· Sesen Bio, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Proxinium, covering 2015-12-23 to 2015-12-23. Get the full timeline:

Most recent: Clinical Trial Update: Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer [Phase 2]